US Patent 10557119 Erythroid cells comprising phenylalanine ammonia lyase
Patent 10557119 was granted and assigned to Rubius Therapeutics on February, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 10, 2019
Date of Patent
February 11, 2020
Patent Applicant
Patent Application Number
16409576
Patent Citations
Patent Inventor Names
Noubar B. Afeyan
0
David Arthur Berry
0
John Round
0
Jordi Mata-Fink
0
Avak Kahvejian
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10557119 Erythroid cells comprising phenylalanine ammonia lyase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
